CalciMedica is trading at $0.75 (+6.46%) in pre-market with no clear company-specific catalyst found following its close at $0.70 on July 20, 2026.

  • The move appears to be a continuation of recent volatility in the thinly traded microcap name rather than a response to fresh news.
  • No new company announcements, earnings releases, or FDA/regulatory updates have been reported.
  • Broader technology sector sentiment is positive pre-market, though there is no direct evidence that market strength is the primary driver.